Rodman David Malcom

Chief Medical Officer

1 company

Good

Trades Analyzed

12M Win Rate

37.5%

Avg 3M Return

+1.4%

Avg 12M Return

-44.1%

Rodman David Malcom is a Chief Medical Officer at Mineralys Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 15 sells.

Estimated insider holdings value: $2.1M based on current market prices.

Holdings by Company

MLYSApr 17, 2026

Current Shares70.2K

Value$2.06M

Net Activity-730,929

Bought: 0Sold: 730.9K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 14, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	11,366	$14.59	$165,878.81	-10.4%	+186.6%	-
Jun 13, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	11,366	$14.60	$165,931.10	-10.1%	+159.5%	-
May 14, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sell	11,366	$15.29	$173,773.64	-9.6%	-10.6%	-
Apr 14, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	11,366	$14.53	$165,185.14	-4.7%	+7.9%	+91.2%
Apr 1, 2025	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	55,771	$15.76	$879,008.48	-12.3%	-2.2%	+90.8%
Nov 11, 2024	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	5,026	$15.00	$75,398.04	-3.4%	-36.3%	+215.8%
Nov 6, 2024	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	25,482	$15.03	$383,065.81	-15.8%	-31.7%	+147.6%
Jul 16, 2024	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	525	$15.00	$7,875.58	-0.5%	-6.8%	-1.8%
May 9, 2024	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	100	$15.00	$1,500.00	-0.1%	-21.0%	+2.7%
Aug 11, 2023	MLYS Mineralys Therapeutics, Inc.	Chief Medical Officer	Sale+OE	231,716	$12.92	$2,994,400.71	-100%	-42.2%	-14.0%